Associate Professor of Medicine

Departmental Address:
Traylor Building
Room 912
720 Rutland Avenue
Baltimore, MD 21205

Administrative Office:
410-614-0167
410-614-0854 (fax)
Schedule an Appointment:
410-955-3142

Clinical/Academic Interests

Myeloproliferative Disorders, Thrombocytopenia, Hypercoaguable States

Research Interests

Dr. Moliterno's major clinical research involves the study of the chronic myeloproliferative disorders (MPDs) including polycythemia vera, essential thrombocytosis and idiopathic myelofibrosis.  Her research is focused on the genetic and epigenetic lesions associated with the MPDs with the goal of improving diagnosis and treatment for these disorders.

Education/Training

• BA, Physics, Cornell University
• MD, State University of New York State at Buffalo
• Internship and Residency in Medicine,  Johns Hopkins Bayview Medical Center
• Clinical Fellowship, Johns Hopkins University School of Medicine
• Research Fellowship, Johns Hopkins University School of Medicine

Selected Publications

Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll R, Spivak JL. Mpl Baltimore: A Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11444-7.

Segal J, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Ann Epidemiol. 2006 Feb;16(2):123-30

Moliterno AR, Williams D, Rogers O, Spivak JL. Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between Quantitative JAK2 V617F and Mpl Expression. Blood. 2006 Dec 1;108(12):3913-5.

Pemmaraju N, Moliterno AR, Williams D, Rogers O, Spivak JL. Quantitative JAK2 V617F Neutrophil Allele Burden Does Not Correlate with Thrombotic Risk in Essential Thrombocytosis.2007 Oct;21(10):2210-2.

Williams DR, Kim AH, Rogers O, Spivak JL, Moliterno AR. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis and idiopathic myelofibrosis. Exp Hematol. 2007 Nov; 35(11):1641-6.

Moliterno AR, Williams D, Rogers O, Isaacs MA, Spivak JL. Phenotypic variability within the JAK2 V617F-positive MPD: The roles of progenitor cell and neutrophil allele burdens. Exp Hematol.  2008 Nov;36(11):1480-6.

Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Yang Y, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human iPS cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009 Dec 24;114(27):5473-80.

Stein B, Williams D, Rogers O, Isaacs MA, Spivak JL, Moliterno AR. Sex differences in the JAK2^V617F allele burden in the Chronic Myeloproliferative Disorders. Haematologica.  2010 Jul 95(7):1090-7

Laughlin TS, Moliterno AR, Stein BS, Rothberg PG. Detection of Exon 12 Mutations in the JAK2 Gene: Enhanced Analytical Sensitivity using Clamped PCR and Nucleotide Sequencing.  J Mol Diagn.  2010 May;12(3):278-82.

Stein BL, Moliterno AR. Primary Myelofibrosis and the Myeloproliferative Neoplasms: The Role of Individual Variation.  JAMA. 2010 Jun 23;303(24):2513-8.